Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$945.6M
63M shares
52-week range
$13.67 – $15.80
78% from low
Exchange
NYSE
FUND
Borrow rate
0.35%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $5.2M | $59.7M | −$26.0M | $8.2M | $24.1M |
| Cost of revenue | $0 | $0 | $0 | $0 | −$8.5M | $0 |
| Gross profit | $0 | $5.2M | $6.4M | −$26.0M | $28.9M | $24.1M |
| Gross margin | — | 100.0% | 10.7% | 100.0% | 352.4% | 100.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $0 | $68.9K | $53.9K | $1.5M | $8.5M | $927.2K |
| EBITDA | $0 | $0 | $53.9K | −$26.5M | $20.0M | $927.2K |
| Net income | $0 | $79.6M | $59.1M | −$26.5M | $20.0M | $23.5M |
| Net margin | — | 1517.9% | 99.1% | 101.9% | 244.3% | 97.4% |
| EPS (diluted) | 1.45 | 11.63 | -2.55 | -2.10 | 1.44 | 1.77 |
Annual figures · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| BMEZBlackRock Health Sciences Term Trust | $15.33 | +1.32% | $1.6B | — |
| BCATBlackRock Capital Allocation Trust | $16.07 | +1.58% | $1.7B | — |
| BDJBlackRock Enhanced Equity Dividend Trust | $9.55 | +1.60% | $1.7B | — |
| BSTBlackRock Science and Technology Trust | $49.06 | +2.17% | $1.7B | — |
| BTTBlackrock Municipal 2030 Target Term Trust | $22.63 |
BlackRock Health Sciences Term Trust is a closed-end fund focused on the healthcare and health sciences sector. Its investment objectives are to provide total return and income through long-term capital appreciation.
www.blackrock.comNo one on the platform currently holds BMEZ.
No tracked institution reports a position in BMEZ as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-09-15 | $0.1100 | 2026-09-30 |
| 2026-08-14 | $0.1100 | 2026-08-31 |
| 2026-07-15 | $0.1100 | 2026-07-31 |
| 2026-06-15 | $0.1100 | 2026-06-30 |
| 2026-05-15 | $0.1100 | 2026-05-29 |
| 2026-04-15 | $0.1100 | 2026-04-30 |
| 2026-03-13 | $0.1100 | 2026-03-31 |
| 2026-02-13 | $0.1100 | 2026-02-27 |
| 2026-01-20 | $0.1100 | 2026-01-30 |
| 2025-12-22 | $0.1100 | 2025-12-31 |
No one on the platform has traded BMEZ yet.
| +0.09% |
| $1.4B |
| — |
| ECATBlackRock ESG Capital Allocation Trust | $15.64 | +2.16% | $1.6B | — |
| FGTRXFranklin Growth Allocation R | $23.09 | +1.01% | $1.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2025-11-14 |
| $0.1100 |
| 2025-11-28 |
| 2025-10-15 | $0.1100 | 2025-10-31 |
Trading at 3.6× sales vs its 26.3× historical median P/S.
Fair value ≈ $111.42 · price $15.33 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$BST $BTX $NASA got some space x, anthropic, open AI, Anduril exposure now, among others. At significant NAV discount no less for first two I expect these to really be hit at some point between now and IPO time (maybe starting with today's decline lol) but they should be worthwhile long term Hedging with boring $BOE $BMEZ Cefconnect.com shows great discount to NAV for those as well
View on StockTwits ↗$GAB $ETG $BMEZ some more I added given valuations. Very far from NAV per Cefconnect.com
View on StockTwits ↗$VCX funny $BMEZ $NBXG $BSTZ already do this and pay huge dividends too
View on StockTwits ↗$SLS hey $BLK $BMEZ $BTX time to load up on $SLS https://www.clinicaltrials.gov/study/NCT04229979?cond=NCT04229979&rank=1
View on StockTwits ↗$BMEZ The thesis is evolving from vision-led to process-driven as scrutiny intensifies. Strategic direction should avoid unnecessary detours. Operational wins could gradually shift expectations upward. Without confirmation, volatility likely persists.
View on StockTwits ↗$BMEZ Current Stock Price: $14.95 No options data available.
View on StockTwits ↗$BMEZ short every single move higher in this pos fund
View on StockTwits ↗$BMEZ while the same name ETF $BMED was up today this pos closed end fund lost .42%.
View on StockTwits ↗$BMEZ one of the worst managed funds in the biotech space. NAV literally ALWAYS lags on up days. I can’t find another biotech fund that does worse
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.